It could transform our understanding of why diseases develop and the medicines needed to treat them, says researchers.
Researchers have identified a protein pattern that, already at birth, looks markedly different in those who later go on to ...
Researchers from Mass General Brigham and Albert Einstein College of Medicine identified molecular changes associated with type 2 diabetes risk, reflecting contributions from genetics, diet, and ...
Background: Diabetic foot ulcer (DFU) is a common and serious complication in patients with diabetes, which affects the quality of life greatly as well as brings high risk for mortality.
(NEXSTAR) – The Food and Drug Administration has issued an Early Alert in response to “a potentially high-risk issue” concerning faulty glucose monitor sensors. The sensors, produced by Abbott ...
It’s far from news to any business leader that our current rate of cyberattacks has become a serious problem. In 2024, 72% of organizations reported an increase in cyber risks, driven by the growing ...
CVS has agreed to pay almost $38 million to settle allegations that its pharmacies overcharged the government for insulin pens over a decade, putting to bed a Department of Justice lawsuit and several ...
Researchers at the University of Waterloo in Ontario, Canada, have developed a new method of analyzing social media posts to help identify growing vaccine skepticism. Vaccines have been under fire in ...
Every Monday morning, leaders across industries open their inboxes to a deluge of Requests for Proposal (RFPs). Some are worth chasing; others are high-effort, low-return distractions. The challenge ...
The NFL thrives on routine, so it’s no surprise that the workweek for many teams begins the same way. On Monday morning, as coaches break down film, trainers, strength coaches and data analysts fire ...
A team of Mayo Clinic scientists have created a way to estimate a person’s risk of developing memory and thinking problems long before symptoms of Alzheimer’s disease begin, potentially changing how ...
ATLANTA -- Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of gestational diabetes but not pre-eclampsia during pregnancy, according to a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results